All Roll Calls
Yes: 284 • No: 148
Sponsored By: Karrie K. Delaney (Democratic)
To Governor
Prescription Drug Affordability Board established; drug cost affordability review. Establishes the Prescription Drug Affordability Board for the purpose of protecting the citizens of the Commonwealth and other stakeholders within the health care system from the high costs of prescription drug products. The bill requires the Board to meet in open session at least four times annually, with certain exceptions and requirements enumerated in the bill. Members of the Board are required to disclose any conflicts of interest, as described in the bill. The bill also creates a stakeholder council for the purpose of assisting the Board in making decisions related to drug cost affordability. The bill tasks the Board with identifying prescription, generic, and other drugs, as defined in the bill, that are offered for sale in the Commonwealth and, at the Board's discretion, conducting an affordability review of any prescription drug product. The bill lists factors for the Board to consider that indicate an affordability challenge for the health care system in the Commonwealth or high out-of-pocket costs for patients. The bill also provides that any person aggrieved by a decision of the Board may request an appeal of the Board's decision and that the Attorney General has authority to enforce the provisions of the bill. The bill provides that the Board shall establish no more than 12 upper payment limit amounts annually between July 1, 2026, and January 1, 2029.The bill requires the Board to annually report its findings and recommendations to the General Assembly, beginning on December 31, 2026. Provisions of the bill apply to state-sponsored and state-regulated health plans and health programs and obligate such policies to limit drug payment amounts and reimbursements to an upper payment limit amount set by the Board, if applicable, following an affordability review. The bill specifies that Medicare Part D plans are not bound by such decisions of the Board.The bill also requires the nonprofit organization contracted by the Department of Health to provide prescription drug price transparency to provide the Board access to certain data reported by manufacturers. The bill has a delayed effective date of July 1, 2026.
Personalized for You
Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Karrie K. Delaney
Democratic • House
There are no cosponsors for this bill.
All Roll Calls
Yes: 284 • No: 148
House vote • 2/19/2025
Senate substitute agreed to by House
Yes: 52 • No: 45
Senate vote • 2/18/2025
Passed Senate with substitute
Yes: 26 • No: 14
Senate vote • 2/18/2025
Reconsideration of Senate passage agreed to by Senate
Yes: 40 • No: 0
Senate vote • 2/18/2025
Passed Senate with substitute
Yes: 24 • No: 16
Senate vote • 2/17/2025
Constitutional reading dispensed Block Vote (on 2nd reading)
Yes: 39 • No: 0
Senate vote • 2/14/2025
Reported from Finance and Appropriations with substitute
Yes: 10 • No: 4
Senate vote • 2/10/2025
Reported from Commerce and Labor and rereferred to Finance and Appropriations
Yes: 10 • No: 5
House vote • 1/31/2025
Read third time and passed House
Yes: 52 • No: 44
House vote • 1/27/2025
Reported from Appropriations
Yes: 14 • No: 8
House vote • 1/24/2025
Subcommittee recommends reporting
Yes: 5 • No: 2 • Other: 1
House vote • 1/14/2025
Reported from Labor and Commerce and referred to Appropriations
Yes: 12 • No: 10
House sustained Governor's veto
Vetoed by Governor
Governor's Action Deadline 11:59 p.m., March 24, 2025
Enrolled Bill communicated to Governor on March 11, 2024
Signed by President
Fiscal Impact Statement from Department of Planning and Budget (HB1724)
Enrolled
Signed by Speaker
Fiscal Impact Statement from Department of Planning and Budget (HB1724)
Senate substitute agreed to by House (52-Y 45-N)
Passed Senate with substitute (26-Y 14-N)
Reconsideration of Senate passage agreed to by Senate
Passed Senate with substitute (24-Y 16-N)
Engrossed by Senate - committee substitute
Finance and Appropriations Substitute agreed to
Read third time
Reading of substitute waived
Constitutional reading dispensed Block Vote (on 2nd reading) (39-Y 0-N)
Passed by for the day
Rules suspended
Reported from Finance and Appropriations with substitute (10-Y 4-N)
Committee substitute printed 25107574D-S1
Reported from Commerce and Labor and rereferred to Finance and Appropriations (10-Y 5-N)
Referred to Committee on Commerce and Labor
Constitutional reading dispensed (on 1st reading)
Veto Explanation
3/24/2025
Enrolled
3/7/2025
Substitute
2/17/2025
Introduced
1/4/2025
HR671, Commending JR's Auto Care.
Commending JR's Auto Care.
SB941, Robbery; use of air or gas operated weapon, etc., penalty.
Robbery; air or gas operated weapon, etc.; penalty. Expands the crime of Class 3 felony robbery to include robbery committed by any person by using or displaying any air or gas operated weapon or any object similar in appearance to a firearm, whether capable of being fired or not.
HB1746, Public safety officer; definition.
Public safety officer; definition. Adds dispatchers and animal control officers to the definition of a public safety officer for purposes of possible selection by the Governor for the Commonwealth Public Safety Medal of Valor, presented for performance above and beyond the call of duty involving extraordinary valor in the face of grave danger, at great personal risk. However, the bill specifies that dispatchers and animal control officers are not included in the definition of public safety officer for the purpose of an injury where weather constitutes a particular risk of a public safety officer's employment to be compensable under the Virginia Workers' Compensation Act.
HB1600, Budget Bill.
Budget Bill. Amends items of and adds items to Chapter 2 of the Acts of Assembly of 2024, Special Session I.
SB1449, Data centers; site assessment for high energy use facility.
Siting of data centers; site assessment; high energy use facility. Provides that prior to any approval of a rezoning application, special exception application, or special use permit for the siting of a new high energy use facility (HEUF), as defined in the bill, a locality shall require that an applicant perform and submit a site assessment to examine the sound profile of the HEUF on residential units and schools located within 500 feet of the HEUF property boundary. The bill also allows a locality to require that a site assessment examine the effect of the proposed facility on (i) ground and surface water resources, (ii) agricultural resources, (iii) parks, (iv) registered historic sites, and (v) forestland on the HEUF site or immediately contiguous land. The provisions of the bill shall not apply to a site with an existing legislative or administrative approval where an applicant is seeking an expansion or modification of an already existing or approved facility and such expansion does not exceed an additional 100 megawatts or more of electrical power. Finally, the bill provides that its provisions shall not be construed to prohibit, limit, or otherwise supersede existing local zoning authority. This bill is identical to HB 1601.
HB1609, Essential health benefits benchmark plan; Commission to consider coverage for infertility treatment.
Health insurance; coverage for fertility services; essential health benefits benchmark plan. Requires the Health Insurance Reform Commission to consider coverage for the diagnosis and treatment of infertility and for standard fertility preservation procedures in its 2025 review of the essential health benefits benchmark plan.